|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Depreciation and amortization | |||||
| Depreciation, amortization and accretion | |||||
| Deferred tax (benefit) expense | |||||
| Tax receivable agreements expense | |||||
| (Gain) loss on disposal of property and equipment and divestitures | |||||
| Equity in losses of unconsolidated entities | |||||
| Credit loss expense | |||||
| Amortization of debt issuance costs | |||||
| Amortization and write off of debt issuance costs | |||||
| Inventory adjustments | |||||
| Equity-based compensation | |||||
| Impairments and abandonments | |||||
| Remeasurement gain on business combination | |||||
| Other operating items, net | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property and equipment | |||||
| Purchase of equity-method investment | |||||
| Acquisitions, net of cash received | |||||
| Proceeds received from sales of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Borrowings from revolving line of credit | |||||
| Payments on revolving line of credit | |||||
| Borrowings from long-term debt | |||||
| Payments of finance lease obligations | |||||
| Payment of debt issuance costs | |||||
| Dividends and distributions paid | |||||
| Proceeds from share issuance | |||||
| Payments under tax receivable agreements | |||||
| Distributions to noncontrolling interests | |||||
| Contributions from noncontrolling interests | |||||
| Repurchase of common stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental cash flow disclosure: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net | |||||
| Supplemental disclosure of noncash operating activities: | |||||
| Asset retirement obligation revisions | |||||
| Lease liabilities arising from obtaining right-of-use assets | |||||
| Supplemental disclosure of noncash investing activities: | |||||
| Issuance of shares for acquisitions | |||||
| Issuance (recoupment) of shares for acquisitions | |||||
| Assets and liabilities transferred in business combination | |||||
| Property and equipment obtained by assuming liabilities | |||||
| Capital expenditures included in accounts payable and accrued liabilities | |||||
Loading...
